Biotech | April 20, 2026
Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
